Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 USD | -1.97% | -2.80% | -6.08% |
Chart calendar Pasithea Therapeutics Corp.
Upcoming events on Pasithea Therapeutics Corp.
No events available
Past events on Pasithea Therapeutics Corp.
2023-12-28 | Annual General Meeting |
2023-12-19 09:00 am | Annual General Meeting |
2023-09-11 12:00 am | H.C. Wainwright Global Investment Conference |
2023-06-25 07:00 pm | Neurofibromatosis Conference |
2023-05-09 | EF Hutton Global Conference |
2023-03-04 11:30 am | American Association Advancement of Science Meeting |
2023-02-22 | Americas Committee for Treatment and Research in Multiple Sclerosis Forum |
2022-12-08 | Extraordinary Shareholders Meeting - Proxy Fight |
2022-12-06 | Antibody Engineering & Therapeutics Conference |
2022-11-29 09:00 am | Extraordinary Shareholders Meeting |
2022-10-13 | Immunotherapy International Course and Symposium |
2022-10-12 09:00 am | Acquisition of AlloMek Therapeutics LLC By Pasithea Therapeutics Corp Call |
2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
2022-08-30 09:00 am | From Laboratory to Clinic International Conference |
2022-06-27 10:30 am | H.C. Wainwright Mental Healthcare Conference |
2022-06-23 09:00 am | Annual General Meeting |
2022-06-22 09:00 am | Acquisition of Alpha-5 integrin, LLC by Pasithea Therapeutics Corp Call |
2022-04-21 12:30 pm | NobleCon18 Conference |
2022-03-30 04:15 pm | FY 2021 Earnings Release |
2021-09-30 10:10 am | Benzinga Healthcare Small Cap Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,02 0,10 -84.94% | 0,49 0,50 -2.69% |
EBITDA Million USD | Released Forecast Spread | 0,00 | -4,51 -2,90 -55.38% | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -4,51 -3,30 -36.59% | 0,00 0,00 - |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | -0,04 | 0,00 0,00 - | 0,00 0,00 - |
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 13/04/21 | 30/03/22 | 30/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,02 0,10 -84.94% | 0,01 0,30 -95.45% | 0,01 0,50 -97.28% | 0,22 0,10 118.61% | 0,24 0,30 -19.76% | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -1,96 -0,70 -180% | -2,40 -1,50 -59.97% | -2,51 -2,50 -0.4% | ||||
EBIT Million USD | Released Forecast Spread | -1,96 -0,80 -144.53% | -3,08 -2,60 -18.47% | |||||
Announcement Date | 30/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 12/05/23 | 11/08/23 |
Past sector events for Pasithea Therapeutics Corp.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- KTTA Stock
- Calendar Pasithea Therapeutics Corp.